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Abstract
Objective: Iron deficiency still remains the most common nutritional deficiency throughout the world and is the
leading cause of anaemia in children. Early recognition of iron deficiency, even before the development of anaemia
is crucial to prevent the systemic complications of this disease.
Methods: Ninety-seven school children between 5 and 16 years were stratified into prelatent iron deficiency (10
cases), latent iron deficiency (14 cases), overt iron deficiency anemia (13 cases), and controls (60 cases). All
hemograms were performed on the same day of collection using the same Sysmex XE-2100 analyzer with
reticulocyte indices included. Biochemical markers such serum iron, total iron binding capacity and percent
saturation (calculated) in addition to serum ferritin and serum transferrin receptors were simultaneously measured.
Data analysis was done using ANOVA test, generalized linear regression, and ROC curve.
Results: Our study indicates that a panel based on hematologic parameters including reticulocyte hemoglobin at
a cut off of ≤27 and ≤25.6, serum transferrin receptors at a cut off >0.48 and >0.68, red cell distribution width at a cut
off >13.8 and >16.8 may provide an alternative to the traditional biochemical panels for the diagnosis of latent iron
deficiency and overt iron deficiency anemia respectively.
Conclusion: Whenever iron deficiency is thought of, a hemogram including reticulocyte hemoglobin and serum
transferrin receptors would be the adequate diagnostic panel obviating the need for a more extensive one. These
parameters should always be interpreted in the clinical context involving dietary habits, social standard as well as
family history.
Keywords: Iron deficiency; School children; Reticulocyte
hemoglobin
Introduction
Iron deficiency (ID) still remains the most common nutritional
deficiency throughout the world and is the leading cause of anaemia in
children. Iron deficiency occurs in stages starting with a non-anemic
phase which was described as early as 1968 by Heinrich [1] as prelatent
and latent stages with the former being characterized by depleted iron
stores with normal serum iron and transferrin levels, reflecting the
body’s versatile ability to compensate. Latent ID on the other hand
reflects a more advanced stage where depletion of iron starts to show
peripherally with lowering of serum iron and microcytosis, thus
reflecting a state of iron deficient erythropoiesis. Clinical iron
deficiency or iron deficiency anaemia is a further deterioration when
the body eventually succumbs to the limited resources especially in the
face of increased demand as is the case with growing children and
adolescents.
Although anaemia can be reversed with iron supplementation, the
alteration in cognitive performance observed in children with iron
deficiency may not be fully correctable [2]. Iron deficiency even
without anemia is also associated with adverse effects on
neurocognitive development [3] and evidence that these effects may be
permanent is mounting [4,5]. For example, children who had chronic
iron deficiency in infancy had poorer mental and motor functioning
when compared with their non–iron-deficient counterparts more than
10 years later [6]. Early recognition of iron deficiency, even before the
development of anaemia is therefore crucial to prevent the systemic
complications of this disease. Consequently, replenishment of the
body’s iron stores will take not only less time and therefore be cost
effective, but also will limit the time patients are exposed to the
unpleasant side effects of iron therapy and consequently ensure better
adherence to therapy.
The diagnosis of simple iron deficiency has been traditionally based
on a panel of biochemical indicators of iron metabolism, which
includes the determination of serum or plasma iron, transferrin,
transferrin saturation and ferritin. However these are liable to
biological variability, such as diurnal variation, fluctuation with dietary
intake, and as acute phase reactants, alteration in inflammatory states.
Hematological tests are more widely used to screen for iron deficiency.
Hemoglobin is the most commonly used hematological screening test,
but it is derived from the entire population of red blood cells, each
with a lifespan of about 120 days, and therefore takes some time to be
altered by iron deficiency. Consequently, relying on hemoglobin for
screening will delay the detection of iron deficiency in infants who are
not yet anemic but for whom adverse neurological consequences may
have already begun to occur. More recently measurements of soluble
transferrin receptors (sTfR) and reticulocyte cellular indices have been
added to the diagnostic menu [7-10].
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Objectives
To compare the true predictive value of reticulocyte hemoglobin
(RetHe) to the standard haematological and biochemical parameters
in the early detection of iron deficiency and to set local Ret He cutoff
values for delineating iron deficient states.
Design and Methods
A cohort of 97 school children presenting to the pediatric clinic, age
ranging from 5-16 were included in the study, consisting of 58 Qataris,
39 non-Qataris, male/female was 43/54. To all cases complete blood
count and iron study were ordered as part of the routine investigation.
Known thalassemic patients or those showing thalassemic indices,
those on iron therapy, those with combined B12/folate deficiency, with
signs of infection or who have received blood transfusion within the
previous 4 months were excluded.
Study design
Samples were collected for the routine investigation ordered by the
physician. Serum separated from the amount of blood left-over in the
tubes after performing the requested tests was divided into aliquots
and kept at -70°C for later assessment of serum transferrin receptors
(sTfR).
All samples were collected from 7-11 am to avoid the effect of
diurnal variation on iron status.
All complete blood pictures were performed on the same day of
collection using the same automated analyzer (Sysmex XE-2100,
software # 00-33, Sysmex, Kobe, Japan) with reticulocyte indices
included. The counter is calibrated initially and checked daily
according to the manufacturer’s instructions and with materials
provided by the manufacturer.
Biochemical markers such serum iron, total iron binding capacity
and percent saturation (calculated) were processed on automated
Hitachi Modular B-800 (Roche Diagnostics, Indianapolis, IN, USA).
Serum ferritin was measured by on the Architect iSR2000 (Abbott
Laboratories, Abbott Park, Illinois, U.S.A.).
SerumTfR were measured in serum using the Cobas® STFR kit, a
particle enhanced immunoturbidimetric assay processed on the
Hitachi/Roche Cobas c501 analyzer (Roche Diagnostics, Indianapolis,
IN, USA)
Ninety-seven children were enrolled in the study, of whom 43
(44.3%) were males. The median age of participants was 9 years. Cases
were classified into 3 main groups. Those with a normal CBC and iron
status study falling within the normal limits were termed “Controls”
(60 cases).
The remaining cases were divided according to percent saturation
of iron into prelatent IDA (≥15%) (10 cases) and iron deficiency
(<15%).
The latter group was further subdivided according to drop of
hemoglobin and reduction of mean corpuscular volume into latent (14
cases) and overt IDA (13 cases) (Figure 1).
Figure 1: Classification of all subjects under study.
Data Management and Analysıs Plan
Statistical analysis
We used SAS version 9.1.3 (SAS Institute Inc., Cary, NC) and
DTREG version 6.1. to conduct the analysis. We checked the data for
normality and outliers. If the normality assumption was violated, we
log transformed the variables as necessary. Spearman correlation
coefficients were used to assess the relationship between continuous
variables, and one-way analysis of variance (ANOVA) was conducted
for comparison of group means (Kruskal-Wallis test was used if
normality assumption was violated). We used Spearman’s correlation
coefficients to assess the correlations between categorical variables,
and Chi-square analysis to test for differences in proportions (Fisher’s
exact test, if the assumptions underlying chi-square were violated).
We used generalized linear regression models to test for significant
predictors iron deficiency indices and if it varies by gender, age,
nationality.
We used area under the receiver operating characteristic (ROC)
curve to determine a cutoff point of RetHe that could be used as
predictor of iron deficiency anemia (IDA). We considered the ROC
curves acceptable if AUC was >75%, negative likelihood ratio<0.5, and
positive likelihood ratio>2. We defined the negative predictive value
(NPV) as the probability of being non-anemic among those classified
as non-anemic by the chosen cut off point i.e. the number of truly
non-anemic divided by the total number of non-anemic by the cut off
point (the sum of true and false negative) multiplied by 100.
The test positive predictive value (PPV) was defined as the
probability of being an anemic among those classified as anemic by the
chosen cut off point i.e. the number of truly anemic divided by the
total number diagnosed as anemic by the cut off point (the sum of true
and false positive) multiplied by 100.
Results
The study included 97 subjects (60 controls, and 37 patients).
Patients represented different iron deficiency stages, including
prelatent (10), latent (14), and overt (13) (Figure 1).
The median age of study participants was 9 years (inter-quartile
range 7-12). Iron deficiency status did not vary by gender (X2=0.17,
p=0.920) or age (X2=1.85, p=0.174). Reticulocyte hemoglobin content,
transferrin receptors, and red cell distribution width did not
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significantly vary by nationality or gender (p>0.05). Reticulocyte
hemoglobin content (p=0.043) but not transferrin receptors and red
cell distribution width (p=0.085, 0.124 respectively) significantly
varied by age.
Levels of reticulocyte hemoglobin content (Tables 1-4 and Figure
2a), transferrin receptors (Table 1 and Figure 2b), and red cell
distribution width table and Figure 2c), significantly varied by iron
deficiency status (p<0.001).
Figure 2: Distribution of iron deficiency indices by iron deficiency status.
In contrast, reticulocyte hemoglobin content, transferrin receptors
and red cell distribution width did not significantly vary by nationality
or gender (p>0.05). Reticulocyte hemoglobin content (p=0.008) but
not transferrin receptors and red cell distribution width (p=0.084, and
0.124 respectively) significantly varied by age.
 Iron Deficiency Status
Controls Pre-latent Latent Overt
Median IQR Median IQR Median IQR Median IQR
Age 9 6.0-11.5 7.5 7.0-9.0 7.5 7.0-11.0 13 6.8-16.0
% saturation 21.4 16.3-29.2 16.9 15.4-19.4 10.2 8.2-12.3 5.1 5.1-7.5
Hemoglobin (g/dl) 12.7 12.2-13.1 12.1 11.2-12.5 11.8 11.6-12.3 9.4 9.3- 10.1
Haematocrit % 38.2 37.1-40.4 36.71 34.8-39.3 36.1 35.2-37.4 32.4 31.8-34.3
Immature reticulocyte
fraction
3.4 2.0-4.9 2.71 2.4-3.9 4.4 3.7-6.7 9.3 6.5-9.9
Mean corpuscular
hemoglobin
concentration
32.8 32.2-33.5 31.9 31.5-32.9 32.4 31.6-32.8 29 29.0-30.0
Mean corpuscular
hemoglobin
26.3 25.4-27.5 26.4 24.0-27.0 24.3 23.3-26.7 19.9 18.3-20.6
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Mean corpuscular
volume
80.5 78.0-83.0 78.9 77.6-82.2 81.1 78.3-82.6 68.6 64.8-69.3
IQR: inter-quartile range  
 Iron Deficiency Status
Controls Pre-latent Latent Overt
Median IQR Median IQR Median IQR Median IQR
Red blood cell count (106/ul) 4.8 4.6-5.1 4.6 4.6-5.1 4.6 4.4- 5.1 4.7 4.7 – 5.0
Red blood cell distribution width% 13.4 12.8-13.8 15.1 13.7-15.4 15 14.3-15.3 18.2 17.4-19.0
Reticulocytes 53.8 45.2-65.5 46.7 41.4-53.8 51.2 41.4-57.1 45.8 41.5-49.1
Reticulocyte hemoglobin content 29.4 28.0-30.7 28 27.6-29.9 26.3 25.6-27.9 18.7 18.6-22.2
Reticulocytes % 1.1 0.9-1.4 1 0.9-1.1 1.1 0.8-1.16 1 0.8-1.0
Serum ferritin 28.5 20.5-37.5 7 5.0-8.0 5.5 4.0-7.0 2 2.0-5.3
Serum iron 13 11.0-18.0 11 11.0-13.0 7 5.0-9.0 4 4.0-5.5
Transferrin receptors 0.4 0.3-0.4 0.5 0.5-0.6 0.6 0.5-0.6 0.8 0.8-1.0
Total iron binding capacity 60.5 55.5-66.5 64.5 62.0-68.0 70 64.0-74.0 78 74.8- 80.0
IQR: inter-quartile range
Table 1: Characteristics of study population by iron deficiency status.
Status Comparison Difference
Between
Simultaneous 95%
Confidence Limits
 
Means
Prelatent-Latent 2.14 0.11 4.4  
Prelatent-Overt 8.17 5.88 10.46 ***
Latent-Control -2.99 -4.86 -1.13 ***
Latent-Overt 6.02 3.6 8.45 ***
Overt-Control -9.02 -10.95 -7 ***
Control-Prelatent 0.85 -1.01 2.71  
Comparisons significant at the 0.05 level are indicated by ***
Table 2: Comparison of reticulocyte hemoglobin content among
different iron deficiency status.
Status Comparison Difference
Between
Means
Simultaneous 95%
Confidence Limits
 
Prelatent-Latent -0.06 -0.2 0.08  
Prelatent-Overt -0.36 -0.5 -0.22 ***
Latent-Control 0.2 0.1 0.29 ***
Latent-Overt -0.3 -0.42 -0.17 ***
Overt-Control 0.49 0.4 0.59 ***
Control-Prelatent -0.13 -0.25 -0.02 ***
Comparisons significant at the 0.05 level are indicated by ***
Table 3: Comparison of serum transferrin receptors among different
iron deficiency status.
Status
Comparison
Difference
Between
Means
Simultaneous 95%
Confidence Limits
 
Prelatent-Latent -0.3 -1.4 0.8  
Prelatent-Overt -3.45 -4.58 -2.33 ***
Latent-Control 1.62 0.83 2.42 ***
Latent-Overt -3.16 -4.19 -2.13 ***
Overt-Control 4.78 3.96 5.6 ***
Control-Prelatent -1.32 -2.24 -0.41 ***
Comparisons significant at the 0.05 level are indicated by ***
Table 4: Comparison of red blood cell distribution width% among
different iron deficiency status.
ROC Curve Analysis
Reticulocyte hemoglobin content
Reticulocyte hemoglobin content did not yield ROC curves with
area under the curve (AUC) >75%, thus no cutoff points were
considered strong enough to predict pre-latent IDA.
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However, reticulocyte hemoglobin content significantly predicted
latent IDA (AUC=85.9% (95% CI 76.6-92.5%), with a cutoff <27,
sensitivity=0.7 specificity=0.86, PPV=0.43, NPV=0.95, +LR=5.00, and
-LR=0.33) and overt IDA (AUC=98.1% (95% CI 93.0-99.8%), with a
cutoff <25.6, sensitivity=0.9 specificity=0.94, PPV=0.70, NPV=0.99,
+LR=15.50, and -LR=0.08) (Figures 3-5).
Figure 3: Receiver operating characteristic curves of reticulocyte
hemoglobin content. Reticulocyte hemoglobin content: ≤28.0,
sensitivity=0.60, specificity=0.75, PPV=0.20, NPV=0.95, +LR=2.40,
-LR=0.53 with an AUC=63.6% (95% CI 51.2-74.8%) did not
significantly predict pre-latent IDA.
Figure 4: Receiver operating characteristic curves of reticulocyte
hemoglobin content. Reticulocyte hemoglobin content: <27.0,
sensitivity=0.71, specificity=0.86, PPV=0.43, NPV=0.95, +LR=5.00,
and -LR=0.33 with an AUC=85.9% (95% CI 76.6-92.5%)
significantly predicted latent IDA.
Figure 5: Receiver operating characteristic curves of reticulocyte
hemoglobin content. Reticulocyte hemoglobin content: ≤ 25.6,
sensitivity=0.92, specificity=0.94, PPV=0.68, NPV=0.99,
+LR=15.50, -LR=0.08 with an AUC=98.1% (95% CI 93.0-99.8%)
significantly predicted overt IDA.
Transferrin receptors
Figure 6: Receiver operating characteristic curves of transferrin
receptors. Transferrin receptors: >0.48, sensitivity=0.70,
specificity=0.98, PPV=0.81, NPV=0.96, +LR=42.00, -LR=0.31 with
an AUC=83.6% (95% CI 72.8-91.4%) significantly predicted pre-
latent IDA.
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Figure 7: Receiver operating characteristic curves of transferrin
receptors. Transferrin receptors: >0.48, sensitivity=0.86,
specificity=0.89, PPV=0.53, NPV=0.98, +LR=7.50, -LR=0.16 with
an AUC=93.7% (95% CI 84.8-97.2%) significantly predicted latent
IDA.
Transferrin receptors significantly predicted pre-latent IDA
(AUC=83.6% (95% CI 72.8-91.4%), with a cutoff >0.48
sensitivity=0.70, specificity=0.98, PPV=0.87, NPV=0.95, +LR=42.00,
and -LR=0.31), latent IDA (AUC=93.7% (95% CI 84.8-97.2%), with a
cutoff >0.48, sensitivity=0.86, specificity=0.89, PPV=0.53, NPV=0.98,
+LR=7.50, and -LR=0.16) and overt IDA (AUC=96.2% (95% CI
90.2-99.0%), with a cutoff >0.68, sensitivity=0.85, specificity=0.96,
PPV=0.77, NPV=0.98, +LR=23.69, and -LR=0.16) (Figures 6-8).
Figure 8: Receiver operating characteristic curves of transferrin
receptors. Transferrin receptors: >0.68, sensitivity=0.85,
specificity=0.96, PPV=0.77, NPV=0.98, +LR=23.69, and -LR=0.16
with an AUC=96.2% (95% CI 90.2-99.0%) significantly predicted
overt IDA.
Red cell distribution width
Red cell distribution width significantly predicted pre-latent IDA
(AUC=80.8% (95% CI 69.6-98.2%), with a cutoff >13.8
sensitivity=0.70, specificity=0.78, PPV=0.35, NPV=0.94, +LR=3.23,
and -LR=0.38), latent IDA (AUC=93.4% (95% CI 86.8-100%), with a
cutoff >13.8, sensitivity=0.93, specificity=0.78, PPV=0.39, NPV=0.98,
+LR=3.25, and -LR=0.10) and overt IDA (AUC=97.4% (95% CI
91.1-99.6%), with a cutoff >16.8, sensitivity=0.85, specificity=1.00,
PPV=1.00, NPV=0.98, and -LR=0.15) (Figures 9-11).
Figure 9: Receiver operating characteristic curves of red cell
distribution width. Red cell distribution width: >13.8,
sensitivity=0.70, specificity=0.78, PPV=0.35, NPV=0.94, +LR=3.23,
-LR=0.38 with an AUC=80.8% (95% CI 72.8-91.4%) significantly
predicted pre-latent IDA.
Figure 10: Receiver operating characteristic curves of red cell
distribution width. Red cell distribution width: >13.8,
sensitivity=0.93, specificity=0.78, PPV=0.39, NPV=0.98, +LR=4.29,
-LR=0.09 with an AUC=93.4% (95% CI 86.8-100%) significantly
predicted latent IDA.
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Figure 11: Receiver operating characteristic curves of red cell
distribution width. Red cell distribution width: >16.8,
sensitivity=0.85, specificity=0.96, PPV=1.00, NPV=0.98, and -
LR=0.15 with an AUC=97.4% (95% CI 91.1-99.6%)significantly
predicted overt IDA.
ROC curve comparison
We compared whether reticulocyte hemoglobin content is a better
predictor of IDA status compared to transferrin receptors and red cell
distribution width.
Transferrin receptors ROC curve was a better than reticulocyte
hemoglobin content ROC curve and red cell distribution width in
predicting pre-latent IDA (z=1.90, p=0.057; and z=2.20, p=0.028
respectively). In contrast, there was no significance difference between
the three curves in predicting latent IDA (z=1.20, p=0.213; z=0.30,
p=0.764 respectively) or overt IDA (z=1.20, p=0.229; z=0.38, p=0.705
respectively).
Discussion
The present study reflects how technological evolution in
automated haematology analyzers over the last 2 decades would help
in the diagnosis of iron deficiency and iron deficiency anaemia,
commonly seen in children and adolescents worldwide. Introduction
of new physical principles for cellular analysis and the progressive
evolution of software resulted in improvement in analytic efficiency
and an increase in the information provided. Reticulocyte parameters
provided by the Sysmex XE 2100, and previously on the Advia
analyzer is one example. Our study further reinforced the value of
RetHe in the diagnosis of both latent and overt iron deficiency.
Traditionally, the diagnosis of iron deficiency relies on the
hematological markers (hemoglobin, mean corpuscular volume
(MCV), mean corpuscular hemoglobin (MCH), red cell distribution
width (RDW) and biochemical markers (serum ferritin (SF), serum
iron (SI), transferrin saturation (TS), total iron-binding capacity
(TIBC) [11,12]. Our study shows that retHe is superior to this panel of
tests in the detection of iron deficiency as early as its latent stage. This
is in accordance with previous reports [13-16], which showed that
determination of the reticulocyte hemoglobin content may allow real-
time evaluation of iron deficiency and concluded that it is to be used as
a marker of iron deficiency. Failure of RetHe to predict the prelatent
stage of iron deficiency can be overcomed by a close look at the RDW
CV % which is significantly increased compared to normal controls
(p<0.0005). When there is insufficient iron for normal haemopoiesis,
the circulation contains a mixture of normal cells and microcytes, so
the RDW-CV% increases rapidly, well before the overall levels of
MCV and Hb drop below the normal range. Few clinicians and public
health workers know about this parameter in spite of the fact that
extensive studies have pointed to its value as an early predictor of iron
deficiency [17-19]. Patients at the prelatent stage are easily missed
since they are usually asymptomatic and probably discovered by
chance when their haemogram is done as part of a routine check up or
as pre-operative investigation. Clinicians should be attracted to the
increased RDW when all other parameters fall within the normal
range since diagnosing iron deficiency at this very early stage can be
rapidly corrected by short courses of iron supplementation while
sparing the patients both the cost and the unwanted side effects of
therapy. Short courses will also help patients’ adherence to therapy and
thence a successful outcome.
Serum transferrin receptor (sTfR) originates mostly from
erythroblasts and lesser from reticulocytes. The usefulness of sTfR has
been implicated in several clinical situations, mainly as a marker of
accelerated erythropoiesis or iron deficiency [20]. The assessment of
sTfR may be useful in the period of rapid growth during infancy,
childhood and adolescence. It has the advantage of being a valuable
non-invasive tool for the diagnosis of iron depletion and an attractive
supplement to more conventional laboratory tests in the detection of
depleted iron stores [21]. Our data show that the level of sTfR
receptors is a sensitive diagnostic tool of ID in school children as early
as the prelatent stage. This in accordance with various studies which
showed that circulating sTfR level was a sensitive indicator of iron
depletion [22-28].
We demonstrated in the current study that RetHe and sTfR are as
sensitive in the detection of both latent and overt IDA with sTfR being
superior to RetHe in the prelatent stage. However, RetHe still retains
the advantage of being measured as a by-product of routine
haemogram at a little increment of cost within the same EDTA-blood
sample with the result gained in less than an hour. Conversely, sTfR
assay is run as separate test requiring specific reagents, another blood
sample, and using a different analyzer with all its requirements.
Conclusion
A diagnostic approach based exclusively on hematologic parameters
obtained by the complete blood cell count and the reticulocyte analysis
is likely more appealing for both its direct assessment of iron
metabolism and its potential cost-effectiveness. A significant reduction
in the expense and the amount of blood needed for testing is an ideal
combination especially when medical laboratories consider the best
and newest specifications when procuring new analyzers. It is true that
new technologies call for bigger budgets, however this can be
neutralized when estimating cost-effectiveness and a multi-
dimensional approach that involves at its very end the benefits of early
diagnosis, shorter therapeutic courses and limited patients’ follow up
both at the clinic and lab wise.
Early detection of iron deficiency is crucial to proper management
and cost effectiveness. Care givers are aware of the unpleasant side
effects of iron therapy which may interfere with patients’ adherence to
therapy that will eventually lead to poor response, financial exhaustion
and possibly late detrimental effect on physical and cognitive health
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especially in this group of fast growing school children and
adolescents. Physicians have to abandon overuse of clinical labs by the
proper use of all information available in the values of red cell indices.
A single sensitive test may provide the same information obtained by
an extensive panel.
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